Markets

Market Nav

RATIO ANALYSIS

You can view the ratio analysis for the last 5 years.
Transgene Biotek Ltd.
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)-0.09-0.09-0.79-1.37-1.38
Diluted EPS (Rs.)-0.09-0.09-0.79-1.37-1.38
Cash EPS (Rs.)-0.07-0.07-0.13-0.06-0.06
Book Value[Excl.RevalReserv]/Share (Rs.)1.321.411.502.292.94
Book Value[Incl.RevalReserv]/Share (Rs.)1.321.411.502.292.94
Revenue From Operations / Share (Rs.)0.030.030.010.010.02
PBDIT / Share (Rs.)-0.04-0.05-0.11-0.03-0.03
PBIT / Share (Rs.)-0.05-0.06-0.76-1.34-1.34
PBT / Share (Rs.)-0.08-0.08-0.79-1.37-1.38
Net Profit / Share (Rs.)-0.08-0.08-0.79-1.37-1.38
NP After MI And SOA / Share (Rs.)-0.08-0.08-0.79-1.37-1.38
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)-130.37-184.80-1592.36-290.36-153.56
PBIT Margin (%)-166.12-224.09-10578.68-11737.81-5997.29
PBT Margin (%)-259.34-279.05-10907.92-11999.39-6154.34
Net Profit Margin (%)-259.34-279.05-10907.92-11999.39-6154.34
NP After MI And SOA Margin (%)-259.34-279.05-10907.92-11999.39-6154.34
Return on Networth / Equity (%)-6.74-6.11-52.85-59.86-46.92
Return on Capital Employeed (%)-0.32-0.40-4.41-7.37-7.12
Return On Assets (%)-0.46-0.46-4.22-7.07-6.65
Long Term Debt / Equity (X)0.600.470.430.270.20
Total Debt / Equity (X)1.451.311.150.690.50
      
LIQUIDITY RATIOS     
      
Current Ratio (X)0.090.090.080.070.04
Quick Ratio (X)0.090.090.080.060.04
Inventory Turnover Ratio (X)7.680.010.000.000.00
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)-1.40-3.36-4.84-1.11-0.97
Interest Coverage Ratio (Post Tax) (%)-1.78-4.08-32.13-44.87-38.19
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)39.6275.6731.9839.3546.01
EV / Net Operating Revenue (X)151.97322.14580.49453.84271.36
EV / EBITDA (X)-116.56-174.31-36.45-156.30-176.71
MarketCap / Net Operating Revenue (X)97.36262.57342.50315.51204.68
Price / BV (X)2.535.761.661.571.56
Price / Net Operating Revenue (X)98.53262.58355.71328.18208.18
EarningsYield-0.02-0.01-0.31-0.38-0.30
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
PER SHARE RATIOS 
Basic EPS (Rs.)-0.09
Diluted EPS (Rs.)-0.09
Cash EPS (Rs.)-0.07
Book Value[Excl.RevalReserv]/Share (Rs.)1.32
Book Value[Incl.RevalReserv]/Share (Rs.)1.32
Revenue From Operations / Share (Rs.)0.03
PBDIT / Share (Rs.)-0.04
PBIT / Share (Rs.)-0.05
PBT / Share (Rs.)-0.08
Net Profit / Share (Rs.)-0.08
NP After MI And SOA / Share (Rs.)-0.08
PROFITABILITY RATIOS 
PBDIT Margin (%)-130.37
PBIT Margin (%)-166.12
PBT Margin (%)-259.34
Net Profit Margin (%)-259.34
NP After MI And SOA Margin (%)-259.34
Return on Networth / Equity (%)-6.74
Return on Capital Employeed (%)-0.32
Return On Assets (%)-0.46
Long Term Debt / Equity (X)0.60
Total Debt / Equity (X)1.45
LIQUIDITY RATIOS 
Current Ratio (X)0.09
Quick Ratio (X)0.09
Inventory Turnover Ratio (X)7.68
COVERAGE RATIOS 
Interest Coverage Ratio (%)-1.40
Interest Coverage Ratio (Post Tax) (%)-1.78
VALUATION RATIOS 
Enterprise Value (Cr.)39.62
EV / Net Operating Revenue (X)151.97
EV / EBITDA (X)-116.56
MarketCap / Net Operating Revenue (X)97.36
Price / BV (X)2.53
Price / Net Operating Revenue (X)98.53
EarningsYield-0.02